Monte Rosa Therapeutics Inc (GLUE)
8.48
-0.15
(-1.74%)
USD |
NASDAQ |
Nov 14, 16:00
8.48
0.00 (0.00%)
After-Hours: 05:28
Monte Rosa Therapeutics Total Assets (Quarterly): 344.11M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 344.11M |
| March 31, 2024 | 266.75M |
| December 31, 2023 | 303.76M |
| September 30, 2023 | 252.10M |
| June 30, 2023 | 278.62M |
| March 31, 2023 | 309.03M |
| December 31, 2022 | 342.39M |
| September 30, 2022 | 357.60M |
| Date | Value |
|---|---|
| June 30, 2022 | 365.06M |
| March 31, 2022 | 346.00M |
| December 31, 2021 | 366.33M |
| September 30, 2021 | 384.05M |
| June 30, 2021 | 368.94M |
| March 31, 2021 | 180.60M |
| December 31, 2020 | 49.38M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
49.38M
Minimum
Dec 2020
384.05M
Maximum
Sep 2021
300.98M
Average
342.39M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Novartis AG | 103.52B |
| MEI Pharma Inc | 41.38M |
| Evoke Pharma Inc | 14.15M |
| Revance Therapeutics Inc | 461.56M |
| Vera Therapeutics Inc | 368.56M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 119.44M |
| Shareholders Equity (Quarterly) | 224.67M |
| Current Ratio | 6.562 |